ANP, Mann Cottage
Editor-in-Chief, Primary Care Issues & Answers
Consultant in Paediatric Liaison in CAMHS, St Mary’s Hospital
Honorary Senior Clinical Lecturer Imperial College London
Dr Taylor is an enthusiastic Child & Adolescent Psychiatrist, therapist and educator and has been employed as a Consultant with CNWL mental health NHS since 2005 working across the range of Child mental health problems. She provides paediatric Liaison consultation to St Mary’s Hospital, London, working at the interface between paediatrics and child mental health. Prior to becoming a child psychiatrist, Sharon completed MRCP qualification in paediatrics.
In the last year Dr Taylor has collaborated in a number of research projects and papers into Long Covid and has been involved in setting up Long Covid clinics for children and adults.
Dr Taylor is involved in training both medical students and postgraduate training in child psychiatry. Dr Taylor has authored over 30 publications, including 7 books, chapters and papers in peer-reviewed journals in the field of Long Covid, Paediatrics and Child Psychiatry.
Faculty of Medicine, Department of Surgery & Cancer
Chair in Medical Informatics and Decision Making
I am a leading exponent internationally of the "Learning Health System" (LHS) concept. Although my initial training in research was in heath technology assessment, real-world (pragmatic) clinical trials and clinical research in Family Medicine, since 2003 I have worked in the area of Clinical Informatics, being appointed to a Chair in Medical Informatics at Imperial in 2015 and elected one of the first 100 founding fellows of the new UK Faculty of Clinical Informatics in 2017. I have had wide exposure to European and US clinical informatics through workshops and symposia.
I was the UK lead investigator on an NIH Clinical Research Roadmap project (The Electronic Primary Care Research Network. HHS268N200425212C) 2006-10. From 2010-15 I led a €9million EU FP7 programme, "TRANSFoRm: Patient Safety and Translational Research in Europe".
TRANSFoRm set about using ontologies, data standards and models to create a common infrastructure for the LHS with three specific use cases (eSource for clinical trials, phenomics and clinical diagnosis.
Prior to moving to Imperial I was Wolfson Professor of General Practice at King's College London. At Imperial, I work in the Institute of Global Health Innovation, with research in Artificial Intelligence, cancer diagnosis and learning systems, eSource for clinical trials and global eHealth. I sit on the Cancer Research UK Population research funding panel and the Medical Research Council Methodology Research panel.
Clinical Director for Primary Care Development: SHFT
GP Partner: Willow Group
PCN Clinical Director: Gosport Central
I qualified as a GP in 2008, and worked in both London and Winchester as a GP Partner, before moving to Gosport in 2017. We are a relatively unique GP Practice, delivering our services in partnership with Southern Health NHS Foundation Trust. This collaboration has helped to sustain the delivery of primary care in Gosport to over 36000 of our residents. From the Better Local Care MCP Vanguard through to the development of Primary Care Networks, we have continued to transform our services in response to the needs of both our patients and staff, developing new models of care delivered by multi-disciplinary teams. I am passionate about working in collaboration with our partners in health, social care and education, our patients and our voluntary organisations to provide holistic care and support. I am the Clinical Director for Gosport Central PCN, and have worked in roles as the Clinical Director for our SHFT services in Portsmouth and the Southeast, incorporating Mental Health, Physical Health, Palliative Care and our Community Services, and more recently as the Clinical Director for Primary Care Development across SHFT, supporting our transformation programmes and partnership working with Primary Care. More recently, in my role as Clinical Director for Primary Care development, I worked as part of a leadership team to support the design and implementation of the Hampshire and Isle of Wight Long COVID service, delivered through partnership working, multi-professional teams and the use of digital technology.
NIHR Research Professor and Margaret Turner Warwick Chair of Thoracic Medicine
Head of Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London
Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London. He is based at the Guy Scadding Building at the Brompton Campus where he is Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Gisli also holds Honorary contracts with the Royal Brompton and Harefield NHS Foundation Trust and with the Imperial College Healthcare NHS Trust.
Prof Jenkins' research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. His team works to understand the biological basis for the development of pulmonary fibrosis and aims to translate this understanding in to improved outcomes for patients. Gisli is the Principle Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium. He is the pulmonary fibrosis working group lead for the Genomics England Clinical Interpretation Partnership in Respiratory Medicine and the PHOSP-COVID study. In 2020 he was awarded the ERS Gold Medal in Interstitial Lung Disease.
He completed his medical training at University of Southampton before undertaking postgraduate training in Respiratory Medicine in London. During this time, he undertook basic scientific training funded by an ARC Fellowship and obtained a PhD in Biochemistry from University College, London, before doing post-doctoral studies at University of California, San Francisco, as part of an ARC Clinician Scientist Fellowship. In 2005 he moved to the University of Nottingham as a Clinical Senior Lecturer before being appointed Professor of Experimental Medicine in 2015. In 2021 he was appointed the Margaret Turner Warwick Chair of Thoracic Medicine at Imperial College London.
Professor Jenkins’ research has been published in leading academic journals including the Journal of Clinical Investigation, Lancet Respiratory Medicine, Nature Communications and Science Signalling and his research group has received funding from Academic organisations including the Medical Research Council, the NIHR, the NC3Rs, the Wellcome Trust, Arthritis Research UK and Asthma UK as well as being awarded industrial contracts in collaboration with Biogen, Galecto, GlaxoSmithKline, MedImmune, Novartis and Pliant Therapeutics.
Active in the wider research community, he is joint Editor-in-Chief of Thorax and was Chair of the Science and Research Committee until 2018. Professor Jenkins promotes public patient involvement in biomedical research and is currently a Trustee of the patient charity Action for Pulmonary Fibrosis.
GPwSI, Belfast Trust
Vincent is a sessional GP in Belfast and Bangor, County Down with a particular interest in respiratory medicine. He holds three part-time clinical assistantships, one in adult chest medicine at Belfast City Hospital, one in paediatric asthma at the Royal Belfast Hospital for Sick Children and one in accident and emergency medicine at the Ulster Hospital in Dundonald. In 2009 he was appointed as a GPwSI in COPD by the Belfast Trust. Vincent is a member of both the PCRS and BTS and previously sat on the joint BTS/SIGN Guideline Panel reviewing the asthma guidelines.
Professor of Cardiology, Head of Cardiac Electrophysiology at Imperial College, London
Director of Imperial Centre for Cardiac Engineering and the ElectroCardioMaths Program
He founded the Connected Care Bureau to implement innovative care pathways at Imperial NHS Hospitals – now extended nationally and internationally. He is on the Advisory Board of the UK Institute for Digital Health (DigitalHealth.London), Clinical Advisor to Google Fit & Health, and Chairman of The Internet Hospital (Synergix). His interest in remote monitoring by implanted and wearable technologies is underpinned by a research program funded principally by the British Heart Foundation. With more than 220 peer-reviewed papers and patents in the field, he has a number of international research collaborations, is on the Advisory Boards and Consultant to a number of academic, publishing, commercial and governmental entities in Europe and U.S.A. He is Adjunct Professor, Department of Pharmacology, Columbia University, NY and co-founder of the European Cardiac Arrhythmia Society.
Professor of Pulmonary & Cardiac Rehabilitation, Department of Respiratory Science, University of Leicester.
Head of Pulmonary & Cardiac Rehabilitation, University Hospitals of Leicester NHS Trust.
Sally Singh is Professor of Pulmonary and Cardiac Rehabilitation at the University of Leicester. She is also Head of Pulmonary and Cardiac Rehabilitation at the University Hospitals of Leicester NHS Trust and Director of the Centre for Exercise and Rehabilitation Science, a multidisciplinary group of researchers conducting a range of research projects in the field of exercise and rehabilitation. She is PI for an NIHR Global Research Group exploring culturally appropriate rehabilitation in low and middle income countries. She is the clinical lead for pulmonary rehabilitation as part of National Asthma and COPD Audit Programme (NACAP) and is the lead clinician for the Pulmonary Rehabilitation Service Accreditation Scheme run by the RCP.
She co-chaired the American Thoracic Society /European Respiratory Society guidance on rehabilitation in the hospital and post-hospital phase from a European in the post COVID population and was the lead author on the BTS guidance document for post COVID rehabilitation. She is the clinical lead for the YourCovidRecovery platform, facilitating wider access to a supported programme for individuals recovering post COVID.
GP Principal, Willows Medical Practice, Bradford.
Dr Matthew Fay is a General Practitioner who joined Westcliffe Medical Practice in 1999. This has developed into the Affinity Care, a 27 partner “superpractice” based in Bradford managing 8 GP contracts and providing care for over 64,000 population.
Matthew is the Clinical Chair of the partnership and the clinical director of Affinity Care PCN, but still does regular GP sessions at The Willows in Queensbury. In 2001 Matthew established a GPwSI cardiology service in Bradford which has expanded to provide direct access investigations and e-consultations.
He was a member of the NICE AF Guideline Development Group and was a standing committee member of the NICE Quality Standard Advisory Committee. He is currently a clinical advisor to the AF Association, STARS (the Syncope Trust), Arrhythmia Alliance, on the Expert Advisory Panel for the Stroke Association and on the faculty for Heart Valve Voice. He is a Trustee of the AF Association and Thrombosis UK. He has been involved in service redesign of cardiovascular services with a focus on AF, dysrhythmia and moving services out of hospital for many years. He was the clinical lead of the redesign of the Bradford VTE services to make it completely community and NOAC based.
He has previously worked in Bradford’s PCTs and CCG. As a father of four he insists that he is first and foremost a family doctor.
VTE CNS and joint Anticoagulant Lead, Anticoagulant Clinic, Great Western Hospital.
Sue is the VTE lead at GWHNHSFT and has been responsible for the implementation of NICE CG92 across the Trust since 2010. She is joint manager of the anticoagulant service providing secondary care led anticoagulant monitoring for 5000 patients within a patient population of 500,000. A well-established nurse led clinic exists with DOACs being prescribed first line for many patients. A structured method of follow up has been developed with a regular questionnaire being sent out to ensure patient safety.
Sue has sat as a specialist committee member of the NICE Diagnostics Advisory Committee which produced a guideline and recommendations for the use of the self-testing/monitoring Coaguchek XS system to monitor the coagulation status of people receiving long-term vitamin K antagonist therapy.
Sue has collaborated with the WEASHN in developing a working model for primary care to maximize the number of patients requiring anticoagulation for stroke prevention in atrial fibrillation also working with a multidisciplinary group to develop an algorithm for primary care in relation to management of patients prescribed warfarin and this has been published in GUIDELINES.
Sue has presented on VTE and anticoagulation at several national and international conferences.
Director, Smart Health Solutions
Associate in Nursing, C3 Collaborating for Health
Founder, Learn With Nurses
Clinical Advisor, PHE
Michaela, is a cardiovascular nurse specialist with a unique and varied experience across the NHS and beyond. She developed her passion for prevention over 25 years ago. 2016 she left public health after 16 years and now has a range of roles, Director for Smart Health Solutions, Associate in Nursing for C3 Collaborating for Health and the Clinical Advisor for CVD Prevention at Public Health England.
She has lead on a variety of projects engaging with nurses and health care professionals exploring issues with own health.
She is Chair of HEART UK Health Care Committee, sits on the Guidelines & Information and Nurses working parties of the British and Irish Hypertension Society and elected to the education committee of the Association of Cardiovascular Nursing & Allied Professions.
Being a Trustee at PoTS UK keeps her firmly rooted in the challenges patients face in living with life altering conditions.